Table 3 Future clinical perspective of advanced lycation endproducts
From: The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes
Clinical trials with various anti-AGE interventions |
Feasibility studies in daily clinical practise: |
   -metabolic control (e.g. HbA1c vs AGEs) |
   -tailoring treatment |
   -risk analysis of interventions (e.g. surgery) |
Role of AGEs in subjects with impaired (fasting) glucose tolerance |
Identifying the "vulnerable patient" at risk for cardiovascular disease in e.g. primary care |